Kati Talvinen
kattal@utu.fi +358 29 450 4521 +358 50 340 0809 Kiinamyllynkatu 10 Turku |
- Personalized multifactorial risk assessment in neoadjuvant-treated breast carcinoma (2024)
- Breast Cancer Research and Treatment
- Varying outcomes of triple-negative breast cancer in different age groups-prognostic value of clinical features and proliferation (2022)
- Breast Cancer Research and Treatment
- A prognostic model based on cell-cycle control predicts outcome of breast cancer patients (2020)
- BMC Cancer
- UBR5 Is Coamplified with MYC in Breast Tumors and Encodes an Ubiquitin Ligase That Limits MYC-Dependent Apoptosis (2020)
- Cancer Research
- Tumor-infiltrating lymphocytes and CD8+ T cells predict survival of triple-negative breast cancer (2019)
- Journal of Cancer Research and Clinical Oncology
- Proliferation-associated miRNAs-494, -205, -21 and -126 detected by in situ hybridization: expression and prognostic potential in breast carcinoma patients (2018)
- Journal of Cancer Research and Clinical Oncology
- PTTG1-interacting protein (PTTG1IP/PBF) predicts breast cancer survival (2017)
- BMC Cancer
- Separase is a marker for prognosis and mitotic activity in breast cancer (2017)
- British Journal of Cancer
- Prognostic implications of securin expression and sub-cellular localization in human breast cancer (2016)
- Cellular Oncology
- Solunjakautumista säätelevät proteiinit securin, cdc20 ja cdc27 ennustavat kohonnutta rintasyöpäkuoleman riskiä (2016)
- BestPractice Onkologia ja hematologia
- FHOD1, a Formin Upregulated in Epithelial-Mesenchymal Transition, Participates in Cancer Cell Migration and Invasion (2013)
- PLoS ONE
- Low cdc27 and high securin expression predict short survival for breast cancer patients (2013)
- APMIS
- Securin predicts aneuploidy and survival in breast cancer (2012)
- Histopathology
- Altered expression of p120catenin predicts poor outcome in invasive breast cancer (2010)
- Journal of Cancer Research and Clinical Oncology
- Characterization of Diaphanous-related formin FMNL2 in human tissues. (2010)
- BMC Cell Biology
- Securin promotes the identification of favourable outcome in invasive breast cancer. (2009)
- British Journal of Cancer
- Proliferation marker securin identifies favourable outcome in invasive ductal breast cancer. (2008)
- British Journal of Cancer
- Biochemical and clinical approaches in evaluating the prognosis of colon cancer. (2006)
- Anticancer Research